Tout DSpace

Afficher la notice abrégée

Leukotriene antagonists: As firstline asthmatic therapy: A review

dc.creatorWozniak, G.en
dc.creatorKotrotsiou, E.en
dc.creatorRoupa, Z.en
dc.date.accessioned2015-11-23T10:54:14Z
dc.date.available2015-11-23T10:54:14Z
dc.date.issued2005
dc.identifier.issn10116575
dc.identifier.urihttp://hdl.handle.net/11615/34683
dc.description.abstractAsthma is a chronic inflammatory disorder characterized by airflow obstruction. The development of leukotriene receptor antagonists and synthesis inhibitors in briefly described; and acute exercise, allergen, and aspirin challenge, studies with these agents are reviewed. Clinical studies with leukotriene antagonists and inhibitors have confirmed the central role leukotrienes of in asthma. The new generation of leukotriene receptor antagonist may be suitable as first-line therapy in patients with mild to moderate asthma.en
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-30544448015&partnerID=40&md5=ee5cad69e817f72dd445487b54f59db5
dc.subjectAsthmaen
dc.subjectLeukotriene antagonistsen
dc.subjectTreatmenten
dc.subjectacetylsalicylic aciden
dc.subjectallergenen
dc.subjectarachidonate 5 lipoxygenase activating proteinen
dc.subjectleukotrieneen
dc.subjectleukotriene A4en
dc.subjectleukotriene B4en
dc.subjectleukotriene C4en
dc.subjectleukotriene D4en
dc.subjectleukotriene E4en
dc.subjectleukotriene receptor blocking agenten
dc.subjectmontelukasten
dc.subjectpranlukasten
dc.subjectslow reacting substanceen
dc.subjectzafirlukasten
dc.subjectzileutonen
dc.subjectairway obstructionen
dc.subjectchronic inflammationen
dc.subjectexercise induced asthmaen
dc.subjectforced expiratory volumeen
dc.subjecthumanen
dc.subjectreviewen
dc.titleLeukotriene antagonists: As firstline asthmatic therapy: A reviewen
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée